Veracyte Stock Soars to 52-Week High, Hits $41.46 - Investing.com

Nov 26, 2024 · Veracyte Inc . (NASDAQ: VCYT) stock has reached a notable milestone, soaring to a 52-week high of $41.46. This peak reflects a significant uptrend for the genomic …

CouponFollow Extension

$41.46
OFF

Veracyte Stock Soars To 52-Week High, Hits $41.46 - Investing.com

3 weeks from now

Nov 26, 2024 · Veracyte Inc . (NASDAQ: VCYT) stock has reached a notable milestone, soaring to a 52-week high of $41.46. This peak reflects a significant uptrend for the genomic …

investing.com

$41.46
OFF

Veracyte Stock Soars To 52-Week High, Hits $41.46

3 weeks from now

Nov 26, 2024 · Veracyte Inc . (NASDAQ: VCYT) stock has reached a notable milestone, soaring to a 52-week high of $41.46. This peak reflects a significant uptrend for the genomic …

investing.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

3 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

4 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

4 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

4 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$44.48
OFF

Veracyte Stock Soars To 52-week High Of $44.48 Amid Robust Growth

3 weeks from now

Dec 4, 2024 · In a remarkable display of market confidence, Veracyte Inc (NASDAQ: VCYT) stock has reached a 52-week high, touching $44.48, with a market capitalization of $3.44 billion.

investing.com

$33.35
OFF

Veracyte Stock Soars To 52-week High, Hits $33.35 - Investing.com …

3 weeks from now

Sep 16, 2024 · Veracyte Inc (NASDAQ: VCYT) stock has reached a new 52-week high, touching $33.35 amidst a year marked by robust growth. The company, known for its genomic …

investing.com

$32.88
OFF

Veracyte Stock Soars To 52-week High, Hits $32.88 - Investing.com …

3 weeks from now

The 52-week high milestone underscores the positive sentiment surrounding the company's growth prospects and its strategic initiatives that have resonated well with the market. In other …

investing.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12 - MSN

3 weeks from now

Veracyte Inc . (NASDAQ:VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price climbing to …

msn.com

$33.35
OFF

Veracyte Stock Soars To 52-week High, Hits $33.35 - Investing.com

3 weeks from now

Sep 16, 2024 · Veracyte Inc (NASDAQ: VCYT) stock has reached a new 52-week high, touching $33.35 amidst a year marked by robust growth. The company, known for its genomic …

investing.com

$35.52
OFF

Veracyte Stock Soars To 52-week High, Hits $35.52 - Investing.com …

3 weeks from now

Nov 5, 2024 · Veracyte Inc (NASDAQ: VCYT) stock has reached a new 52-week high, touching $35.52, marking a significant milestone for the genomic diagnostics company. This peak …

investing.com

$32.88
OFF

Veracyte Stock Soars To 52-week High, Hits $32.88 - Investing.com …

3 weeks from now

Aug 15, 2024 · In a remarkable display of market confidence, Veracyte Inc (NASDAQ: VCYT) stock has reached a 52-week high, touching the price level of $32.88. This peak reflects a …

investing.com

$29.42
OFF

Veracyte Stock Soars To 52-Week High, Reaching $29.42

3 weeks from now

Aug 7, 2024 · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company, has achieved a significant milestone as its stock price soared to a 52-week high of $29.42. This …

investing.com

FAQs about Veracyte Stock Soars to 52-Week High, Hits $41.46 - Investing.com Coupon?

How much of Veracyte's stock have insiders sold?

In the past three months, Veracyte insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,008,297.00 in company stock. Only 1.30% of the stock of Veracyte is held by insiders. Read more about Veracyte's insider trading history. ...

Where can I buy Veracyte stock?

Shares of VCYT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Veracyte own? ...

What is the annual revenue of Veracyte?

The latest annual revenue of Veracyte is $117.5 m. Other financial metrics include revenue per employee at $331.9 k. Competitors of Veracyte include Curetis, Biodesix and Roka Bioscience. ...

Why did Goldman Sachs downgrade Veracyte?

Goldman Sachs recently adjusted its stance on Veracyte, downgrading the rating from Buy to Neutral and slightly reducing the price target to $37, attributing this to a potential deceleration in Afrima growth in 2025 due to high market penetration levels. ...